purposes. Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of $20.75 billion and an asset base in North America that includes 35.9 million RSF of operating properties and 3.5 million RSF of Class A/A+ properties undergoing construction. companies to create life-changing scientific and technological innovations. We believe in the utmost professionalism, humility, and teamwork. Our tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science research institutions; U.S. government research agencies; non-profit organizations; and venture capital firms. Alexandria has a productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and long-term asset value.
Logo and founding year from Wikidata.
As recorded by the SEC for this filer.
As recorded by the SEC for this filer.
No related securities.
No related securities.
| Dec FY2014 | 726.9M |
|---|---|
| Dec FY2015 | 843.5M |
| Dec FY2016 | 921.7M |
| Dec FY2017 | 1.1B |
| Dec FY2018 | 1.3B |
| Dec FY2019 | 1.5B |
| Dec FY2020 | 1.9B |
| Dec FY2021 | 2.1B |
| Dec FY2022 | 2.6B |
| Dec FY2023 | 2.9B |
| Dec FY2024 | 3.1B |
| Dec FY2025 | 3B |
| Sep Q3 FY23 | 713.8M |
|---|---|
| Dec Q4 FY23 | 757.2M |
| Mar Q1 FY24 | 769.1M |
| Jun Q2 FY24 | 766.7M |
| Sep Q3 FY24 | 791.6M |
| Dec Q4 FY24 | 788.9M |
| Mar Q1 FY25 | 758.2M |
| Jun Q2 FY25 | 762M |
| Sep Q3 FY25 | 751.9M |
| Dec Q4 FY25 | 754.4M |
| Mar Q1 FY26 | 671M |
| Jun Q2 FY26 | 662.8M |